Improved recombinant human interferon-beta-1b polypeptides

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/21 (2006.01) C07K 14/565 (2006.01)

Patent

CA 2528514

The present invention relates to recombinant human interferon-beta-1b (~IFN- beta-1b~) polypeptides, or fragments analogs, derivatives, or variants thereof, having an improved specific activity. The present invention also relates to pharmaceutical compositions comprising such IFN-beta-1b polypeptides. or fragments, analogs, derivatives, or variants therof, useful for treating multiples sclerosis. The present invention further relates to methods of producing such IFN-beta-1b compositions.

La présente invention a trait à des polypeptides de l'interféron-bêta-1b ( IFN-.beta.-1b ) humains recombinants, ou leurs fragments, analogues, dérivés, ou variants, présentant une activité spécifique améliorée. La présente invention a également trait à des compositions pharmaceutiques comportant de tels polypeptides de IFN-.beta.-1b, ou leurs fragments, analogues, dérivés, ou variants, utiles pour le traitement de la sclérose en plaques. La présente invention a trait en outre à des procédés de production de telles compositions de IFN-.beta.-1b.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Improved recombinant human interferon-beta-1b polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Improved recombinant human interferon-beta-1b polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved recombinant human interferon-beta-1b polypeptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1971453

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.